Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention

International Urology and Nephrology

Volumn 46, Issue 2, 2014, Pages 417-426

  Liu, Yuan Hui ^a   Liu, Yong ^b   Tan, Ning ^a,b   Chen, Ji Yan ^b   Chen, Jin ^b   Chen, Shao Hui ^b   He, Yi Ting ^b   Ran, Peng ^b   Ye, Piao ^b   Li, Yun ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Contrast induced acute kidney injury; Percutaneous coronary intervention

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; FEMALE; GLOBAL REGISTRY FOR ACUTE CORONARY EVENTS RISK SCORES; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE KIDNEY INJURY; AGED, 80 AND OVER; AREA UNDER CURVE; C-REACTIVE PROTEIN; CONTRAST MEDIA; CREATININE; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; ROC CURVE;

EID: 84896844242     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0598-5     Document Type: Article

References (35)

1. McCullough PA, Adam A, Becker CR et al (2006) Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98:5K-13K
2. Wi J, Ko YG, Kim JS et al (2011) Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 97:1753-1757
3. Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44:1780-1785 (Pubitemid 39424075)
4. Cox CD, Tsikouris JP (2004) Preventing contrast nephropathy: what is the best strategy? A review of the literature. J Clin Pharmacol 44:327-337 (Pubitemid 38392006)
5. Mueller C, Buerkle G, Buettner HJ et al (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329-336 (Pubitemid 34127411)
6. Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393-1399 (Pubitemid 39303939)
7. Eagle KA, Lim MJ, Dabbous OH et al (2004) A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291:2727-2733 (Pubitemid 38725422)
8. Pieper KS, Gore JM, FitzGerald G et al (2009) Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J 157:1097-1105
9. Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527-2541
10. Senoo T, Motohiro M, Kamihata H et al (2010) Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105:624-628
11. Kiyokuni M, Kosuge M, Ebina T et al (2012) Impact of the contrast-induced nephropathy definition on long-term outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 126:A11578
12. Liu Y, Tan N, Zhou YL et al (2012) The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention. Int Urol Nephrol 44:221-229
13. Addala S, Grines CL, Dixon SR et al (2004) Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 93:629-632 (Pubitemid 38293076)
14. Halkin A, Singh M, Nikolsky E et al (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45:1397-1405 (Pubitemid 40615609)
15. Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031-2037
16. De Luca G (2004) Suryapranata H, van T HA, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737-2743
17. O'Gara PT, Kushner FG, Ascheim DD et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:e78-e140
18. Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259-2264 (Pubitemid 34535335)
19. Rosenstock JL, Gilles E, Geller AB et al (2010) Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 42:1049-1054
20. Al SJ, Reddan DN, Williams K et al (2002) Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106:974-980 (Pubitemid 34925333)
21. Raposeiras-Roubin S, Aguiar-Souto P, Barreiro-Pardal C et al (2013) GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function. Angiology 64:31-39
22. Patti G, Ricottini E, Nusca A et al (2011) Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty-contrast-induced nephropathy] trial. Am J Cardiol 108:1-7
23. Firouzi A, Eshraghi A, Shakerian F et al (2012) Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients. Int Urol Nephrol 44:1145-1149
24. Yavari V, Ostovan MA, Kojuri J et al (2013) The preventive effect of pentoxifylline on contrast-induced nephropathy: a randomized clinical trial. Int Urol Nephrol. doi:10.1007/s11255-013-0420-4
25. Miao Y, Zhong Y, Yan H et al (2013) Alprostadil plays a protective role in contrast-induced nephropathy in the elderly. Int Urol Nephrol 45:1179-1185
26. Marenzi G, Assanelli E, Marana I et al (2006) N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354:2773-2782 (Pubitemid 43974195)
27. Wu MY, Hsiang HF, Wong CS et al (2013) The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials. Int Urol Nephrol 45:1309-1318
28. Leone AM, De Caterina AR, Sciahbasi A et al (2012) Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study. EuroIntervention 8:839-847
29. Schwedler SB, Kuhlencordt PJ, Ponnuswamy PP et al (2007) Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species. Atherosclerosis 195:e76-e84 (Pubitemid 350087981)
30. Russo D, Minutolo R, Cianciaruso B et al (1995) Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6:1451-1458
31. Bakris GL, Lass NA, Glock D (1999) Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int 56:206-210 (Pubitemid 29300536)
32. Quintavalle C, Fiore D, De Micco F et al (2012) Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 126:3008-3016
33. Gao F, Zhou YJ, Zhu X et al (2011) C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol 34:203-210
34. Liu Y, Tan N, Zhou YL et al (2012) High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol 25:332-340
35. Raposeiras-Roubin S, Barreiro PC, Rodino JB et al (2012) High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score. Angiology 63:30-34